{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:16:55Z","timestamp":1790702215277,"version":"4.1.0"},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,2,2]]},"DOI":"10.18632\/oncotarget.6705","type":"journal-article","created":{"date-parts":[[2015,12,31]],"date-time":"2015-12-31T21:26:11Z","timestamp":1451597171000},"page":"5353-5365","source":"Crossref","is-referenced-by-count":50,"title":["\u03b2-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG"],"prefix":"10.18632","volume":"7","author":[{"given":"Kevin","family":"Lee","sequence":"first","affiliation":[{"name":"Drug Discovery Research Center, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley S.","family":"Lindsey","sequence":"additional","affiliation":[{"name":"Drug Discovery Research Center, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Genetics, The University of Alabama at Birmingham, Birmingham, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Gary","sequence":"additional","affiliation":[{"name":"Drug Discovery Research Center, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Andrews","sequence":"additional","affiliation":[{"name":"Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Keeton","sequence":"additional","affiliation":[{"name":"Drug Discovery Research Center, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Piazza","sequence":"additional","affiliation":[{"name":"Drug Discovery Research Center, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,12,21]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.1073\/pnas.96.12.7071","article-title":"Isolation and characterization of a dual-substrate phosphodiesterase gene family: PDE10A","volume":"96","author":"Beavo","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2","doi-asserted-by":"crossref","first-page":"18438","DOI":"10.1074\/jbc.274.26.18438","article-title":"Cloning and Characterization of a Novel Human Phosphodiesterase That Hydrolyzes Both cAMP and cGMP (PDE10A)","volume":"274","author":"Omori","year":"1999","journal-title":"J Biol Chem"},{"key":"3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-1119(99)00171-7","article-title":"Isolation and characterization of PDE10A, a novel human 3\u2032, 5\u2032-cyclic nucleotide phosphodiesterase","volume":"234","author":"Florio","year":"1999","journal-title":"Gene"},{"key":"4","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1369\/jhc.6A6930.2006","article-title":"Immunohistochemical Localization of Phosphodiesterase 10A in Multiple Mammalian Species","volume":"54","author":"Stephenson","year":"2006","journal-title":"J Histochem Cytochem"},{"key":"5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.neuropharm.2006.01.012","article-title":"Genetic deletion of the striatum-enriched phosphodiesterase PDE10A: Evidence for altered striatal function","volume":"51","author":"Schmidt","year":"2006","journal-title":"Neuropharmacology"},{"key":"6","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1006\/bbrc.1999.1013","article-title":"Characterization and Phosphorylation of PDE10A2, a Novel Alternative Splice Variant of Human Phosphodiesterase That Hydrolyzes cAMP and cGMP","volume":"261","author":"Omori","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"7","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1124\/jpet.109.155994","article-title":"Phosphodiesterase 10A Inhibitor Activity in Preclinical Models of the Positive, Cognitive, and Negative Symptoms of Schizophrenia","volume":"331","author":"Lie","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1124\/jpet.107.132910","article-title":"Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia","volume":"325","author":"Ramirez","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.110.173294","article-title":"Chronic Suppression of Phosphodiesterase 10A Alters Striatal Expression of Genes Responsible for Neurotransmitter Synthesis, Neurotransmission, and Signaling Pathways Implicated in Huntington's Disease","volume":"336","author":"Schmidt","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/onc.2014.94","article-title":"Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and \u03b2-catenin-dependent TCF transcriptional activity","volume":"34","author":"Andrews","year":"2015","journal-title":"Oncogene"},{"key":"11","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-07-6869","article-title":"Activation of Protein Kinase G Increases the Expression of p21CIP1, p27KIP1, and Histidine Triad Protein 1 through Sp1","volume":"68","author":"Weinstein","year":"2008","journal-title":"Cancer Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1158\/1535-7163.MCT-09-0758","article-title":"Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by phosphodiesterase 5 inhibition, elevation of cyclic GMP, and activation of protein kinase G","volume":"8","author":"Piazza","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"13","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/mc.20409","article-title":"Celecoxib-induced growth inhibition in SW480 colon cancer cells is associated with activation of protein kinase G","volume":"47","author":"Weinstein","year":"2008","journal-title":"Mol Carcinog"},{"key":"14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14728222.12.3.367","article-title":"Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer","volume":"12","author":"Browning","year":"2008","journal-title":"Expert Opin Ther Targets"},{"key":"15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s10585-012-9464-6","article-title":"Insidious role of nitric oxide in migration\/invasion of colon cancer cells by upregulating MMP-2\/9 via activation of cGMP-PKG-ERK signaling pathways","volume":"29","author":"Gopala","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1158\/1940-6207.CAPR-11-0559","article-title":"A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and \u03b2-Catenin Transcriptional Activity","volume":"5","author":"Piazza","year":"2012","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"17","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1158\/1535-7163.MCT-13-0048","article-title":"Sulindac Selectively Inhibits Colon Tumor Cell Growth by Activating the cGMP\/PKG Pathway to Suppress Wnt\/\u03b2-Catenin Signaling","volume":"12","author":"Chang","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"18","doi-asserted-by":"crossref","first-page":"3423","DOI":"10.1038\/onc.2010.91","article-title":"PKG inhibits TCF signaling in colon cancer cells by blocking \u03b2-catenin expression and activating FOXO4","volume":"29","author":"Browning","year":"2010","journal-title":"Oncogene"},{"key":"19","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1158\/1940-6207.CAPR-10-0030","article-title":"Colon Tumor Cell Growth-Inhibitory Activity of Sulindac Sulfide and Other Nonsteroidal Anti-Inflammatory Drugs Is Associated with Phosphodiesterase 5 Inhibition","volume":"3","author":"Piazza","year":"2010","journal-title":"Cancer Prev Res (Phila Pa)"},{"key":"20","first-page":"803","article-title":"Vasodilator-stimulated Phosphoprotein (VASP) Phosphorylation Provides a Biomarker for the Action of Exisulind and Related Agents That Activate Protein Kinase G 1 Supported by funds from Cell Pathways, Inc. and awards to I. B. W. from the T. J. Martell Foundation and the National Foundation for Cancer Research. 1","volume":"1","author":"Weinstein","year":"2002","journal-title":"Mol Cancer Ther"},{"key":"21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.12.018","article-title":"Serine phosphorylation of vasodilator-stimulated phosphoprotein (VASP) regulates colon cancer cell survival and apoptosis","volume":"123","author":"Pitari","year":"2015","journal-title":"Life Sci"},{"key":"22","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1158\/1078-0432.CCR-08-1137","article-title":"CREB in the Pathophysiology of Cancer: Implications for Targeting Transcription Factors for Cancer Therapy","volume":"15","author":"Frank","year":"2009","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/hipo.22128","article-title":"PDE10 inhibition increases GluA1 and CREB phosphorylation and improves spatial and recognition memories in a Huntington's disease mouse model","volume":"23","author":"P\u00e9rez-Navarro","year":"2013","journal-title":"Hippocampus"},{"key":"24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/jat.1297","article-title":"Downregulation of human colon carcinoma cell (COLO-205) proliferation through PKG-MAP kinase mediated signaling cascade by E. coli heat stable enterotoxin (STa), a potent anti-angiogenic and anti-metastatic molecule","volume":"28","author":"Chakrabarti","year":"2008","journal-title":"J Appl Toxicol"},{"key":"25","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/jcb.20286","article-title":"Suppression of cyclic GMP-specific phosphodiesterase 5 promotes apoptosis and inhibits growth in HT29 cells","volume":"94","author":"Strada","year":"2005","journal-title":"J Cell Biochem"},{"key":"26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1527-3466.2006.00261.x","article-title":"The Many Faces of H89: A Review","volume":"24","author":"Moolman","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"27","first-page":"1224","article-title":"HT-29 human colon cancer cell proliferation is regulated by cytosolic phospholipase A2\u03b1 dependent PGE2 via both PKA and PKB pathways","volume":"1821","author":"Levy","year":"2012","journal-title":"Biochim Biophys Acta BBA - Mol Cell Biol Lipids"},{"key":"28","doi-asserted-by":"crossref","first-page":"G673","DOI":"10.1152\/ajpgi.00584.2006","article-title":"PGE2 inhibits apoptosis in human adenocarcinoma Caco-2 cell line through Ras-PI3K association and cAMP-dependent kinase A activation","volume":"293","author":"Acquaviva","year":"2007","journal-title":"Am J Physiol - Gastrointest Liver Physiol"},{"key":"29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000066755","article-title":"Wnt\/Beta-Catenin\/Tcf Signaling: A Critical Pathway in Gastrointestinal Tumorigenesis","volume":"66","author":"G\u00f6ke","year":"2002","journal-title":"Digestion"},{"key":"30","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues","volume":"59","author":"Boess","year":"2010","journal-title":"Neuropharmacology"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Nishi, Kuroiwa, Shuto. Mechanisms for the Modulation of Dopamine D1 Receptor Signaling in Striatal Neurons. Front Neuroanat. 2011. [cited 2015 Apr 16]; 5. Available from: http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3140648\/.","DOI":"10.3389\/fnana.2011.00043"},{"key":"32","doi-asserted-by":"crossref","first-page":"33536","DOI":"10.1074\/jbc.M005670200","article-title":"KT5823 Inhibits cGMP-dependent Protein Kinase Activity in Vitro but Not in Intact Human Platelets and Rat Mesangial Cells","volume":"275","author":"Palmetshofer","year":"2000","journal-title":"J Biol Chem"},{"key":"33","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/01.RES.0000091074.33584.F0","article-title":"Role of Phosphodiesterase 3 in NO\/cGMP-Mediated Antiinflammatory Effects in Vascular Smooth Muscle Cells","volume":"93","author":"Yan","year":"2003","journal-title":"Circ Res"},{"key":"34","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/01.STR.0000056527.34434.59","article-title":"Dipyridamole Enhances NO\/cGMP-Mediated Vasodilator-Stimulated Phosphoprotein Phosphorylation and Signaling in Human Platelets In Vitro and In Vivo\/Ex Vivo Studies","volume":"34","author":"Geiger","year":"2003","journal-title":"Stroke"},{"key":"35","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.1021\/jm900521k","article-title":"Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920) for the Treatment of Schizophrenia\u2020\u2020Coordinates of the PDE10A crystal structures have been deposited in the Protein Data Bank for compound 1 (3HQW), 2 (3HQY), 3 (3HQW) and 9 (3HR1)","volume":"52","author":"Schmidt","year":"2009","journal-title":"J Med Chem"},{"key":"36","doi-asserted-by":"publisher","first-page":"27403","DOI":"10.18632\/oncotarget.4741","article-title":"Suppression of \u03b2-catenin\/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10","volume":"6","author":"Wierzbicki","year":"2015","journal-title":"Oncotarget"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6705","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T17:11:54Z","timestamp":1589217114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.6705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,21]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,2,2]]}},"alternative-id":["6705","26713600"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.6705","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,21]]}}}